Clinical outcomes of myeloablative allogeneic peripheral blood stem cell transplantation for relapsed/refractory T-ALL/LBL: A single-center study

Transplant Immunology · Published 2026-06-27 · DOI 10.1016/j.trim.2026.102413

Free full text

Authors (14)

Xiaofan Wang, Linlin Zhang, Yujuan Wu, Sai Xu, Lu Wang, Fei Li, Meng Li, Jian Bo, Lili Wang, Yu Jing, Liping Dou, Daihong Liu, Zhenyang Gu, Chunji Gao

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, X., Zhang, L., Wu, Y., et al. (2026). Clinical outcomes of myeloablative allogeneic peripheral blood stem cell transplantation for relapsed/refractory T-ALL/LBL: A single-center study. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102413

Related articles

• Belatacept in liver transplantation: Results of a national survey among French specialists · Transplant Immunology · 2026 · Same journal
• Advances in biosensors for monitoring immune responses and allograft rejection in organ transplantation · Transplant Immunology · 2026 · Same journal
• Conversion to belatacept-based immunosuppression as a calcineurin sparing regimen in lung transplant: A multi-institutional retrospective study · Transplant Immunology · 2025 · Same journal
• T-cell receptor-engineered T cells (TCR-e T cells): A novel cellular therapy for hematopoietic malignancies? · Transplant Immunology · 2026 · Same journal
• Prolonged cold ischemia promote the progression of chronic allograft nephropathy by chemokine C-C ligand 2 induced macrophage recruitment · Transplant Immunology · 2026 · Same journal
• Evaluation of desensitizing therapies for donor-specific antibodies in confirmed humoral allograft rejection in kidney transplantation: Experience of a center for 10 years · Transplant Immunology · 2026 · Same journal
• Rituximab-based antibody mediated rejection therapy modestly reduces Xenoreactive antibodies: Implications for pig-to-human xenotransplantation · Transplant Immunology · 2025 · Same journal
• Early donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant · Transplant Immunology · 2026 · Same journal
• Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation · Transplant Immunology · 2026 · Same journal
• Exposure to ischemia-related neoepitopes exacerbates secondary ischemia–reperfusion injury in mice · Transplant Immunology · 2026 · Same journal